Stay updated with breaking news from Provides Update. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Some images on this site © 2016 - 2021 Thinkstock CPAC uses cookies to provide you with the best possible browsing experience on our website, and to show you relevant online ads through our advertising partners. By continuing to use our site, you agree to our use of cookies. Visit our Privacy Policy page to learn more or click “I Disagree” to opt-out of advertising cookies.
Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreements with Silicon Valley Bank and Kreos Capital London and Redwood City, Calif., December 15, 2020 - Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) ("Mereo" or "the Company"), a clinical stage biopharmaceutical company focused on oncology and rare diseases, today provided a further update with respect to the cancellation of admission of its Ordinary Shares to trading on AIM and the continued listing of its ADSs on Nasdaq, as o...